|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| C07K 16/18 | |||
| A61K 31/122 | |||
| A61K 31/352 | |||
| A61K 31/565 | |||
| A61K 31/593 | |||
| A61K 31/663 | |||
| A61K 38/23 | |||
| A61K 45/00 | |||
| A61P 19/08 | |||
| A61P 19/10 | |||
| C12N 5/10 | |||
| C12P 21/08 |
| (11) | Patento numeris | 2907826 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15161779.2 |
| Europos patento paraiškos padavimo data | 2008-10-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 2007265420 | 2007-10-11 | JP |
| (72) |
Hiruma, Yoshiharu, JP
Tsuda, Eisuke, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426,
JP
|
| (54) | ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15 |
| ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN SIGLEC-15 |